These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Blood pressure in renal disease: how to accomplish the goal? Robles NR; Hernandez-Gallego R Cardiovasc Ther; 2012 Aug; 30(4):193-8. PubMed ID: 22759229 [TBL] [Abstract][Full Text] [Related]
4. [German Hypertension League update. What does the ALLHAT Study really mean?]. MMW Fortschr Med; 2003 Jun; 145(23):45-6. PubMed ID: 12854226 [No Abstract] [Full Text] [Related]
5. Diuretics are better first-line antihypertensive therapy than calcium channel blockers and ACE inhibitors. Rollins G Rep Med Guidel Outcomes Res; 2003 Jan; 14(2):5-7. PubMed ID: 12776699 [No Abstract] [Full Text] [Related]
6. [Treatment of arterial hypertension. Clinical and pharmacological considerations]. Silva Orrego P; Vera TV; Gual Julia JM; Gabbai F Arch Inst Cardiol Mex; 1987; 57(5):423-31. PubMed ID: 2892470 [No Abstract] [Full Text] [Related]
7. Does it matter how hypertension is controlled? Chobanian AV N Engl J Med; 2008 Dec; 359(23):2485-8. PubMed ID: 19052130 [No Abstract] [Full Text] [Related]
13. Is diltiazem as effective as diuretics and beta-blockers in preventing complications from hypertension? Adelman A J Fam Pract; 2000 Nov; 49(11):1049. PubMed ID: 11093573 [No Abstract] [Full Text] [Related]
14. FDA approves i.v. calcium-channel blocker. Thompson CA Am J Health Syst Pharm; 2008 Sep; 65(18):1686. PubMed ID: 18768991 [No Abstract] [Full Text] [Related]
15. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved. Probstfield J J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849 [No Abstract] [Full Text] [Related]